Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ravi Ramachandran

Orthopaedic Surgery of the Spine Folsom, CA Medical Doctor

NPI 1528242757 CMS profile 204763

13385 Folsom Blvd, Suite 800, Folsom, CA 95630

Open in the dashboard

General payments

$155,963

292 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ravi Ramachandran of Folsom, CA is reported in the CMS Open Payments database as having received $155,963 across 292 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 81st percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $20,680 18
2024 General $12,342 24
2023 General $10,841 34
2022 General $17,524 33
2021 General $38,111 58
2020 General $27,368 54
2019 General $29,096 71

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ravi Ramachandran
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Ravi Ramachandran were reported at $20,680. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Ravi Ramachandran Orthopaedic Surgery of the Spine median Middle half National median
2019 $29,096 $2,106 $337–$18,608 $163
2020 $27,368 $1,213 $156–$15,082 $114
2021 $38,111 $1,834 $271–$15,617 $132
2022 $17,524 $2,015 $320–$17,036 $149
2023 $10,841 $1,925 $336–$14,599 $160
2024 $12,342 $2,110 $341–$12,483 $164
2025 $20,680 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $82,089 94 payments
  2. Spineart USA Inc $39,682 108 payments
  3. Spineart SA $15,212 2 payments
  4. Bioventus LLC $9,766 24 payments
  5. VB Spine LLC $3,449 2 payments
  6. Medtronic USA, Inc. $1,541 17 payments
  7. Medtronic, Inc. $824 7 payments
  8. Precision Spine, Inc. $517 3 payments
  9. Spinal Elements, Inc. $502 3 payments
  10. Globus Medical, Inc. $321 3 payments
  11. Other $2,059 29 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $110,260 49 payments
  2. Food and Beverage $21,259 229 payments
  3. Royalty or License $15,212 2 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,625 2 payments
  5. Travel and Lodging $3,607 10 payments
Products named General payments · program years 2019–2025
  1. PERLA TL $19,953 53 payments
  2. SERRATO Thoracolumbar $15,790 17 payments
  3. SCARLET AC-T - CERVICAL CAGE TI-LIFE $15,212 2 payments
  4. BACS $12,925 6 payments
  5. XIA 3 $11,281 6 payments
  6. CASCADIA $7,774 3 payments
  7. SERRATO Thoracolumbar $7,500 3 payments
  8. MESA $7,265 3 payments
  9. XIA $5,985 5 payments
  10. SCARLET AC-T $4,250 2 payments
  11. Other $48,523 188 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

137

Median for Orthopedic Surgery: 203

Drug cost

$886

Median for Orthopedic Surgery: $1,433

Branded share of claims

20.4%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 109 $613
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 28 $273

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 33 billing codes

Paid by Medicare

$155,972

Medicare's payments for the services billed

Medicare patients

218

Average age 73

Services billed

591

121 women, 97 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 28%
Diabetes 25%
Ischemic heart disease 23%
COPD 18%
Atrial fibrillation 17%
Chronic kidney disease 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

292 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record